Amgen
Trade Amgen 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About AMGN
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K.
AMGN Key Statistics
Stock Snapshot
The current Amgen(AMGN) stock price is $377.83, with a market capitalization of 204.27B. The stock trades at a price-to-earnings (P/E) ratio of 23.34 and offers a dividend yield of 2.65%.
On 2026-09-16, Amgen(AMGN) stock traded between a low of $374.46 and a high of $378.32. Shares are currently priced at $377.83, which is +0.9% above the low and -0.1% below the high.
The Amgen(AMGN)'s current trading volume is 602.74K, compared to an average daily volume of 2.89M.
In the last year, Amgen(AMGN) shares hit a 52-week high of $447.03 and a 52-week low of $269.77.
In the last year, Amgen(AMGN) shares hit a 52-week high of $447.03 and a 52-week low of $269.77.
AMGN News
September is historically known as the worst-performing month for U.S. equities. According to the 2026 Stock Trader’s Almanac, the S&P 500 index has recorded an...
Amgen (NasdaqGS:AMGN) received an FDA label update for IMDELLTRA that shortens recommended monitoring for the first two doses. The revised guidance is expected...
Key Points VanEck Pharmaceutical ETF offers a higher dividend yield and a lower beta profile than VanEck Biotech ETF. VanEck Biotech ETF has delivered a highe...
Analyst ratings
57%
of 35 ratingsMore AMGN News
Veeva Systems (VEEV) announced that Amgen (AMGN) plans to deploy Veeva Vault CRM globally, building on a collaboration spanning more than a decade. “Moving to V...
Amgen Inc (AMGN) announced an update on their ongoing clinical study. The phase 3 study A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluat...
(RTTNews) - Amgen (AMGN) announced the FDA approved an update to the IMDELLTRA Prescribing Information that substantially reduces the recommended monitoring tim...
Key Points Amgen maintains a massive, diversified portfolio of medicines serving approximately 17 million patients globally. Vertex Pharmaceuticals dominates...
Amgen, AstraZeneca Score With Tezspire; Can They Take On Dupixent? 8/27/2026 Amgen and AstraZeneca's drug, Tezspire, scored Thursday in an esophageal disease t...
In early trading on Friday, shares of Honeywell International topped the list of the day's best performing Dow Jones Industrial Average components, trading up 7...
Amgen Inc (AMGN) announced an update on their ongoing clinical study. Amgen Inc. (AMGN) is launching a Phase 4 trial called “A Trial Assessing the Effectivenes...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.